Literature DB >> 19821575

Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.

Robert W Marquis1, Amparo M Lago, James F Callahan, Attiq Rahman, Xiaoyang Dong, George B Stroup, Sandra Hoffman, Maxine Gowen, Eric G DelMar, Bradford C Van Wagenen, Sarah Logan, Scott Shimizu, John Fox, Edward F Nemeth, Theresa Roethke, Brian R Smith, Keith W Ward, Pradip Bhatnagar.   

Abstract

When administered as a single agent to rats, the previously reported calcium receptor antagonist 3 elicited a sustained elevation of plasma PTH resulting in no increase in overall bone mineral density. The lack of a bone building effect for analogue 3 was attributed to the large volume of distribution (V(dss)(rat) = 11 L/kg), producing a protracted plasma PTH profile. Incorporation of a carboxylic acid functionality into the amino alcohol template led to the identification of 12 with a lower volume of distribution (V(dss)(12) = 1.18 L/kg) and a shorter half-life. The zwitterionic nature of antagonist 12 necessitated the utility of an ester prodrug approach to increase overall permeability. Antagonist 12 elicited a rapid and transient increase in circulating levels of PTH following oral dosing of the ester prodrug 11 in the dog. The magnitude and duration of the increases in plasma levels of PTH would be expected to stimulate new bone formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821575     DOI: 10.1021/jm900563e

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery.

Authors:  Bruce J Melancon; Corey R Hopkins; Michael R Wood; Kyle A Emmitte; Colleen M Niswender; Arthur Christopoulos; P Jeffrey Conn; Craig W Lindsley
Journal:  J Med Chem       Date:  2012-01-06       Impact factor: 7.446

2.  Metabolism-guided design of short-acting calcium-sensing receptor antagonists.

Authors:  James A Southers; Jonathan N Bauman; David A Price; Paul S Humphries; Gayatri Balan; John F Sagal; Tristan S Maurer; Yan Zhang; Robert Oliver; Michael Herr; David R Healy; Mei Li; Brendon Kapinos; Gwendolyn D Fate; Keith A Riccardi; Vishwas M Paralkar; Thomas A Brown; Amit S Kalgutkar
Journal:  ACS Med Chem Lett       Date:  2010-05-13       Impact factor: 4.345

3.  Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone.

Authors:  Yuko Shinagawa; Teruhiko Inoue; Takeo Katsushima; Toshihiro Kiguchi; Taku Ikenogami; Naoki Ogawa; Kenji Fukuda; Kazuyuki Hirata; Kazuhito Harada; Masaki Takagi; Takashi Nakagawa; Shuichi Kimura; Yushi Matsuo; Mariko Maekawa; Mikio Hayashi; Yuki Soejima; Mitsuru Takahashi; Masanori Shindo; Hiromasa Hashimoto
Journal:  ACS Med Chem Lett       Date:  2010-12-29       Impact factor: 4.345

4.  Pharmacodynamic model of parathyroid hormone modulation by a negative allosteric modulator of the calcium-sensing receptor.

Authors:  Anson K Abraham; Tristan S Maurer; Amit S Kalgutkar; Xiang Gao; Mei Li; David R Healy; Donna N Petersen; David A Griffith; Donald E Mager
Journal:  AAPS J       Date:  2011-03-25       Impact factor: 4.009

5.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

6.  The vascular Ca2+-sensing receptor regulates blood vessel tone and blood pressure.

Authors:  M Schepelmann; P L Yarova; I Lopez-Fernandez; T S Davies; S C Brennan; P J Edwards; A Aggarwal; J Graça; K Rietdorf; V Matchkov; R A Fenton; W Chang; M Krssak; A Stewart; K J Broadley; D T Ward; S A Price; D H Edwards; P J Kemp; D Riccardi
Journal:  Am J Physiol Cell Physiol       Date:  2015-11-04       Impact factor: 4.249

Review 7.  New concepts in calcium-sensing receptor pharmacology and signalling.

Authors:  Donald T Ward; Daniela Riccardi
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 8.  Therapeutic Opportunities of Targeting Allosteric Binding Sites on the Calcium-Sensing Receptor.

Authors:  Jiayin Diao; Aaron DeBono; Tracy M Josephs; Jane E Bourke; Ben Capuano; Karen J Gregory; Katie Leach
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-08

9.  Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma.

Authors:  Sebastian Frees; Ines Breuksch; Tobias Haber; Heide-Katharina Bauer; Claudia Chavez-Munoz; Peter Raven; Igor Moskalev; Ninadh D Costa; Zheng Tan; Mads Daugaard; Joachim W Thüroff; Axel Haferkamp; Dirk Prawitt; Alan So; Walburgis Brenner
Journal:  Oncotarget       Date:  2018-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.